Delivery Order SPE2DB24D1006-SPE2DB25FCEUC

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a ceiling value of $1,543.62. The contract is a firm fixed price delivery order with a completion date of June 16, 2025. This contract is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime contractor and...
The federal contract award is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency, with a ceiling value of $1,551.02. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 10, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,242.10, is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 4, 2025. The contract was awarded on March 3, 2025 and does not have a set-aside designation,...
This federal contract award, valued at $14,027.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a completion date of May 30, 2025. This is a firm fixed-price delivery order contract, which is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,506.59, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product. The contract has a completion date of February 13, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and...
This contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM pharmaceutical products, with a ceiling value of $4,696.90. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, on March 13, 2025, with a completion date of March 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, valued at $11,661.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a completion date of June 27, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated with any set-aside requirements, indicating open competition....
This federal contract award, valued at $6,598.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a period of performance through April 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,346.72, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 17, 2024. The contract was not designated with a set-aside...
This federal contract award is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,104.02 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024, with a completion date of October 31, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB25FCEUC
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Fluticasone-Salmeterol 230-21 12GM pharmaceutical products to the government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 12, 2025, with a completion date of June 13, 2025 and a ceiling value of $6,500.60. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This contract is associated with Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs.

Generated 9/11/25, 11:00 AM